GENMARK SAGLIK, the most innovative company in molecular diagnostics and molecular level analysis of DNA, RNA and proteins, has employees dedicated to manufacturing and marketing more than 60 products in more than 60 countries worldwide. We are committed to advancing molecular testing solutions that guide life's most important decisions.
We are manufacturing and marketing more than 60 products in more than 60 countries and are committed to advancing molecular testing solutions.
BCR-ABL1 p210 (Mbcr) IS-MMR Kit
The geneMAP™ BCR-ABL1 p210 IS-MMR Kit is intended for the quantitative detection of BCR-ABL1 p210 b2a2 and b3a2 fusion transcripts in bone marrow or peripheral blood samples of patients who have been diagnosed with Acute Lymphoblastic Leukemia (ALL) or Chronic Myeloid Leukemia (CML). This test can be used to monitor Minimal Residual Disease (MRD) in patients undergoing therapy.
A multiplex qPCR kit for the detection of A.baumannii, P.aeruginosa & S.marcescens
Acinetobacter baumannii, Pseudomonas aeruginosa, and Serratia marcescens are all clinically relevant bacterial pathogens that can cause infections in both human and veterinary settings. These pathogens are often associated with healthcare-associated infections, including pneumonia, urinary tract infections, and sepsis. Early detection of these pathogens is crucial to prevent the spread of infections and guide appropriate treatment strategies.
YouSeq's qPCR kit to detect Acinetobacter baumannii, Pseudomonas aeruginosa, and Serratia marcescens allows for rapid and accurate identification of these pathogens, enabling timely intervention and control measures. By detecting these pathogens early, healthcare professionals can take necessary precautions to prevent outbreaks and improve patient outcomes. Detection of these pathogens is essential for infection control and antibiotic stewardship in clinical and environmental settings.
